Emergent BioSolutions Inc.
EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31
Reports and events: 405 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-11-0516:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-20-000160 |
| 2020-08-2606:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000143 |
| 2020-08-0716:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-092005 |
| 2020-08-0520:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-20-000126 |
| 2020-07-3116:52 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001367644-20-000124 |
| 2020-07-3116:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-20-000122 |
| 2020-07-2706:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000112 |
| 2020-07-1406:27 ET | 8-K | 8.01 Other events | 0001367644-20-000110 |
| 2020-07-0606:43 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000108 |
| 2020-06-1116:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-20-000106 |
| 2020-06-0806:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-20-000104 |
| 2020-06-0108:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000098 |
| 2020-05-2817:07 ET | 8-K | 1.01 Entry into a material agreement | 0001367644-20-000088 |
| 2020-05-2717:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001367644-20-000082 |
| 2020-05-0817:11 ET | 8-K | 8.01 Other events | 0001367644-20-000053 |
| 2020-05-0121:54 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000049 |
| 2020-05-0118:16 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001367644-20-000047 |
| 2020-04-3016:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000044 |
| 2020-04-2420:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-20-000039 |
| 2020-04-0917:18 ET | DEF 14A | Proxy statementPeriod 2020-05-21 | 0001047469-20-002226 |
| 2020-02-2518:26 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001367644-20-000010 |
| 2020-02-2016:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-20-000008 |
| 2020-02-1806:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-20-000006 |
| 2020-01-1306:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-20-000002 |
| 2019-11-2116:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-19-000066 |
| 2019-11-0718:02 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001367644-19-000053 |
| 2019-11-0616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-19-000050 |
| 2019-09-0409:26 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-19-000044 |
| 2019-08-0517:04 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001367644-19-000040 |
| 2019-08-0218:24 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001367644-19-000038 |
| 2019-08-0116:29 ET | 8-K | 2.02 Results of operations | 0001367644-19-000036 |
| 2019-05-2316:35 ET | 8-K | 5.07 Shareholder vote results | 0001367644-19-000027 |
| 2019-05-0817:05 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001367644-19-000023 |
| 2019-05-0216:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-19-000019 |
| 2019-04-1217:19 ET | DEF 14A | Proxy statementPeriod 2019-05-23 | 0001047469-19-002216 |
| 2019-02-2221:50 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001367644-19-000016 |
| 2019-02-2116:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-19-000014 |
| 2019-02-1217:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-19-000012 |
| 2019-01-2407:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-19-000010 |
| 2019-01-0706:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-19-000004 |
| 2019-01-0407:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-19-000683 |
| 2018-12-1216:16 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-18-072553 |
| 2018-12-1216:16 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-18-072552 |
| 2018-11-0218:06 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001367644-18-000044 |
| 2018-11-0116:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001367644-18-000042 |
| 2018-10-2509:15 ET | 8-K | 8.01 Other events | 0001367644-18-000039 |
| 2018-10-1517:22 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-062153 |
| 2018-10-0519:22 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-060601 |
| 2018-08-2817:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-18-000037 |
| 2018-08-0906:40 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-18-050726 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.